- Bevorzugter Name
- N-[(3S,6S,12R,15S,16R,19S,22S,24S)-3-benzyl-12-ethyl-24-hydroxy-4,16-dimethyl-2,5,11,14,18,21-hexaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide
- IUPAC
- N-[(3S,6S,12R,15S,16R,19S,22S,24S)-3-benzyl-12-ethyl-24-hydroxy-4,16-dimethyl-2,5,11,14,18,21-hexaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide
- Englischer Name
- dihydrovirginiamycin S1
- Summenformel
- C43H51N7O10
- Molmasse
- 825.91
Namen und Synonyme
Dihydrostaphylomycin SDihydrostaphylomycin S1dihydrovirginiamycin S1Virginiamycin S1, 5-[(2S)-4-hydroxy-2-piperidinecarboxylic acid]- (9CI)N-[(3-Hydroxy-2-pyridinyl)carbonyl]cyclo[L-Thr*-D-Abu-L-Pro-N-methyl-L-Phe-4β-hydroxy-L-Hpr-L-phenyl Gly-]N-[(3-Hydroxy-2-pyridinyl)carbonyl]cyclo[L-Thr*-D-Abu-L-Pro-N-methyl-L-Phe-[(4S)-4-hydroxy-L-pipecoloyl]-L-phenyl Gly-]
Datenbank-Bezeichner
- Nikkaji
- J247.829C